MedPath

OPDUALAG 240 MG/80 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

OPDUALAG 240 MG/80 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Pending
Register Number

1221679001

Prescription Type

Uso Hospitalario

Authorization Date

Jan 10, 2024

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1221679001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

NIVOLUMABActive
Quantity: 255,60 mg
Name: NIVOLUMAB
RELATLIMABActive
Quantity: 85,20 mg
Name: RELATLIMAB

ATC CLASSIFICATION (3)

L01F
L01FY
L01FY02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.